Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Alm Management, 74175-74176 [2022-26208]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 231 / Friday, December 2, 2022 / Notices
lotter on DSK11XQN23PROD with NOTICES1
Basic class
Bezitramide ...........................
Carfentanil ............................
Cocaine .................................
Codeine (for conversion) ......
Codeine (for sale) .................
D-amphetamine (for sale) .....
D,l-amphetamine ..................
d-amphetamine (for conversion) ..................................
Dexmethylphenidate (for
sale) ..................................
Dexmethylphenidate (for
conversion) ........................
Dextropropoxyphene ............
Dihydrocodeine .....................
Dihydroetorphine ..................
Diphenoxylate (for conversion) ..................................
Diphenoxylate (for sale) .......
Ecgonine ...............................
Ethylmorphine .......................
Etorphine hydrochloride ........
Fentanyl ................................
Glutethimide ..........................
Hydrocodone (for conversion) ..................................
Hydrocodone (for sale) .........
Hydromorphone ....................
Isomethadone .......................
L-amphetamine .....................
Levo-alphacetylmethadol
(LAAM) ..............................
Levomethorphan ...................
Levorphanol ..........................
Lisdexamfetamine .................
Meperidine ............................
Meperidine Intermediate-A ...
Meperidine Intermediate-B ...
Meperidine Intermediate-C ...
Metazocine ...........................
Methadone (for sale) ............
Methadone Intermediate .......
Methamphetamine ................
d-methamphetamine (for
conversion) ........................
d-methamphetamine (for
sale) ..................................
l-methamphetamine ..............
Methylphenidate (for sale) ....
Methylphenidate (for conversion) ..................................
Metopon ................................
Moramide-intermediate .........
Morphine (for conversion) ....
Morphine (for sale) ...............
Nabilone ................................
Norfentanyl ...........................
Noroxymorphone (for conversion) ..................................
Noroxymorphone (for sale) ...
Oliceridine .............................
Opium (powder) ....................
Opium (tincture) ....................
Oripavine ..............................
Oxycodone (for conversion)
Oxycodone (for sale) ............
Oxymorphone (for conversion) ..................................
Oxymorphone (for sale) ........
Pentobarbital .........................
Phenazocine .........................
Phencyclidine ........................
VerDate Sep<11>2014
19:14 Dec 01, 2022
Established
2023 quotas
(g)
25
20
60,492
1,085,024
21,003,397
21,200,000
21,200,000
20,000,000
6,200,000
4,200,000
35
132,658
25
14,100
770,800
60,492
30
32
731,452
25
Established
2023 quotas
(g)
Basic class
Phenmetrazine ......................
Phenylacetone ......................
Piminodine ............................
Racemethorphan ..................
Racemorphan .......................
Remifentanil ..........................
Secobarbital ..........................
Sufentanil ..............................
Tapentadol ............................
Thebaine ...............................
List I Chemicals
Ephedrine (for conversion) ...
Ephedrine (for sale) ..............
Phenylpropanolamine (for
conversion) ........................
Phenylpropanolamine (for
sale) ..................................
Pseudoephedrine (for conversion) .............................
Pseudoephedrine (for sale) ..
25
100
25
5
5
3,000
172,100
4,000
11,941,416
57,137,944
47,000
587,229
41,800,000
15,300,000
25
25
2,458,460
21,747,625
62,000
25
22,044,741
1,000
25,100
250,000
530,837
33,010,750
437,827
53,840,608
Signing Authority
This document of the Drug
Enforcement Administration was signed
on November 29, 2022, by
Administrator Anne Milgram. That
document with the original signature
and date is maintained by DEA. For
administrative purposes only, and in
compliance with requirements of the
Office of the Federal Register, the
undersigned DEA Federal Register
Liaison Officer has been authorized to
sign and submit the document in
electronic format for publication, as an
official document of DEA. This
administrative process in no way alters
the legal effect of this document upon
publication in the Federal Register.
Scott Brinks,
Federal Register Liaison Officer, Drug
Enforcement Administration.
[FR Doc. 2022-26351 Filed 11-30-22; 11:15 am]
BILLING CODE P
28,204,371
516,351
33,843,337
25
35
Jkt 259001
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
Drug Enforcement Administration
[Docket No. 1121]
Bulk Manufacturer of Controlled
Substances Application: Bulk
Manufacturer of Marihuana: Alm
Management
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
The Drug Enforcement
Administration (DEA) is providing
notice of an application it has received
41,100
from an entity applying to be registered
4,136,000
to manufacture in bulk basic class(es) of
14,878,320 controlled substances listed in schedule
I. DEA intends to evaluate this and other
7,990,000 pending applications according to its
regulations governing the program of
1,000 growing marihuana for scientific and
174,246,000 medical research under DEA
registration.
The Administrator also establishes
APQ for all other schedule I and II
controlled substances included in 21
CFR 1308.11 and 1308.12 at zero. In
accordance with 21 CFR 1303.13 and 21
25 CFR 1315.13, upon consideration of the
30 relevant factors, the Administrator may
23,010 adjust the 2023 APQ and AAN as
26,500,000 needed.
485,020
DEPARTMENT OF JUSTICE
SUMMARY:
1,250
27,239,822
1,994,117
30
30
681,289
30
30
30
15
25,619,700
27,673,600
150
74175
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before January 31, 2023.
ADDRESSES: DEA requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: The
Controlled Substances Act (CSA)
prohibits the cultivation and
distribution of marihuana except by
persons who are registered under the
CSA to do so for lawful purposes. In
accordance with the purposes specified
in 21 CFR 1301.33(a), DEA is providing
notice that the entity identified below
has applied for registration as a bulk
manufacturer of schedule I controlled
substances. In response, registered bulk
manufacturers of the affected basic
class(es), and applicants therefor, may
submit electronic comments on or
objections of the requested registration,
as provided in this notice. This notice
DATES:
E:\FR\FM\02DEN1.SGM
02DEN1
74176
Federal Register / Vol. 87, No. 231 / Friday, December 2, 2022 / Notices
does not constitute any evaluation or
determination of the merits of the
application submitted.
The applicant plans to manufacture
bulk active pharmaceutical ingredients
(APIs) for product development and
distribution to DEA registered
researchers. If the application for
registration is granted, the registrant
would not be authorized to conduct
other activity under this registration
aside from those coincident activities
specifically authorized by DEA
regulations. DEA will evaluate the
application for registration as a bulk
manufacturer for compliance with all
applicable laws, treaties, and
regulations and to ensure adequate
safeguards against diversion are in
place.
As this applicant has applied to
become registered as a bulk
manufacturer of marihuana, the
application will be evaluated under the
criteria of 21 U.S.C. 823(a). DEA will
conduct this evaluation in the manner
described in the rule published at 85 FR
82333 on December 18, 2020, and
reflected in DEA regulations at 21 CFR
part 1318.
In accordance with 21 CFR
1301.33(a), DEA is providing notice that
on October 25, 2022, Alm Management,
7460 Varna Avenue, North Hollywood,
California 91605, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substances:
Controlled
substance
Drug code
Marihuana .........
7360
Schedule
I
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2022–26208 Filed 12–1–22; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 1122]
Bulk Manufacturer of Controlled
Substances Application: Bulk
Manufacturer of Marihuana: Attitude
Wellness
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
The Drug Enforcement
Administration (DEA) is providing
notice of an application it has received
from an entity applying to be registered
to manufacture in bulk basic class(es) of
controlled substances listed in schedule
I. DEA intends to evaluate this and other
pending applications according to its
regulations governing the program of
growing marihuana for scientific and
medical research under DEA
registration.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before January 31, 2023.
ADDRESSES: DEA requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: The
Controlled Substances Act (CSA)
prohibits the cultivation and
distribution of marihuana except by
persons who are registered under the
CSA to do so for lawful purposes. In
SUMMARY:
accordance with the purposes specified
in 21 CFR 1301.33(a), DEA is providing
notice that the entity identified below
has applied for registration as a bulk
manufacturer of schedule I controlled
substances. In response, registered bulk
manufacturers of the affected basic
class(es), and applicants therefor, may
submit electronic comments on or
objections of the requested registration,
as provided in this notice. This notice
does not constitute any evaluation or
determination of the merits of the
application submitted.
The applicant plans to manufacture
bulk active pharmaceutical ingredients
(APIs) for product development and
distribution to DEA registered
researchers. If the application for
registration is granted, the registrant
would not be authorized to conduct
other activity under this registration
aside from those coincident activities
specifically authorized by DEA
regulations. DEA will evaluate the
application for registration as a bulk
manufacturer for compliance with all
applicable laws, treaties, and
regulations and to ensure adequate
safeguards against diversion are in
place.
As this applicant has applied to
become registered as a bulk
manufacturer of marihuana, the
application will be evaluated under the
criteria of 21 U.S.C. 823(a). DEA will
conduct this evaluation in the manner
described in the rule published at 85 FR
82333 on December 18, 2020, and
reflected in DEA regulations at 21 CFR
part 1318.
In accordance with 21 CFR
1301.33(a), DEA is providing notice that
on October 3, 2022, Attitude Wellness,
9741 South Industrial Drive, Evart,
Michigan 49631, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substances:
lotter on DSK11XQN23PROD with NOTICES1
Controlled
substance
Drug code
Marihuana Extract ...........................................................................................................................................................
Marihuana ........................................................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
VerDate Sep<11>2014
19:14 Dec 01, 2022
Jkt 259001
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
E:\FR\FM\02DEN1.SGM
02DEN1
7350
7360
7370
Schedule
I
I
I
]]>Agencies
[Federal Register Volume 87, Number 231 (Friday, December 2, 2022)]
[Notices]
[Pages 74175-74176]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-26208]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 1121]
Bulk Manufacturer of Controlled Substances Application: Bulk
Manufacturer of Marihuana: Alm Management
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: The Drug Enforcement Administration (DEA) is providing notice
of an application it has received from an entity applying to be
registered to manufacture in bulk basic class(es) of controlled
substances listed in schedule I. DEA intends to evaluate this and other
pending applications according to its regulations governing the program
of growing marihuana for scientific and medical research under DEA
registration.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
January 31, 2023.
ADDRESSES: DEA requires that all comments be submitted electronically
through the Federal eRulemaking Portal, which provides the ability to
type short comments directly into the comment field on the web page or
attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for
submitting comments. Upon submission of your comment, you will receive
a Comment Tracking Number. Please be aware that submitted comments are
not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number,
your comment has been successfully submitted and there is no need to
resubmit the same comment.
SUPPLEMENTARY INFORMATION: The Controlled Substances Act (CSA)
prohibits the cultivation and distribution of marihuana except by
persons who are registered under the CSA to do so for lawful purposes.
In accordance with the purposes specified in 21 CFR 1301.33(a), DEA is
providing notice that the entity identified below has applied for
registration as a bulk manufacturer of schedule I controlled
substances. In response, registered bulk manufacturers of the affected
basic class(es), and applicants therefor, may submit electronic
comments on or objections of the requested registration, as provided in
this notice. This notice
[[Page 74176]]
does not constitute any evaluation or determination of the merits of
the application submitted.
The applicant plans to manufacture bulk active pharmaceutical
ingredients (APIs) for product development and distribution to DEA
registered researchers. If the application for registration is granted,
the registrant would not be authorized to conduct other activity under
this registration aside from those coincident activities specifically
authorized by DEA regulations. DEA will evaluate the application for
registration as a bulk manufacturer for compliance with all applicable
laws, treaties, and regulations and to ensure adequate safeguards
against diversion are in place.
As this applicant has applied to become registered as a bulk
manufacturer of marihuana, the application will be evaluated under the
criteria of 21 U.S.C. 823(a). DEA will conduct this evaluation in the
manner described in the rule published at 85 FR 82333 on December 18,
2020, and reflected in DEA regulations at 21 CFR part 1318.
In accordance with 21 CFR 1301.33(a), DEA is providing notice that
on October 25, 2022, Alm Management, 7460 Varna Avenue, North
Hollywood, California 91605, applied to be registered as a bulk
manufacturer of the following basic class(es) of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Marihuana.......................... 7360 I
------------------------------------------------------------------------
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2022-26208 Filed 12-1-22; 8:45 am]
BILLING CODE 4410-09-P
